STOPCAP M1
Menu
Home
What is STOPCAP M1?
Systematic reviews
The FAME approach
Docetaxel
Zoledronic acid
Abiraterone
Prostate RT
Network
Surrogate outcomes
ICECAP M0
Repository of patient data
Who is running STOPCAP M1?
Programme Management Group
International Advisory Group
Key Collaborators
Collaborative Group
Patient & Public Involvement
PPI and STOPCAP M1
Recent STOPCAP M1 results
Prostate Cancer Resources
News
Search the site
Sitemap
Protocols, SAPS, Appendices
ADT versus ADT + Docetaxel
Protocol v2.0 (13August 2021)
Statistical analysis plan v2.0 (16July2021)
ADT versus ADT + ARSI (with or without docetaxel)
Protocol v4.0 (01February2024)
Statistical analysis plan v3.0 (06February2024)
Network meta-analysis of systemic treatments (ADT, Docetaxel, ARSI)
Protocol v1.0 (01February2024)
Statistical analysis plan v3.0 (07February2024)
Protocol appendices
STOPCAP M1 Charter v2.1 (06Feb2024)
STOPCAP M1 Data transfer guide v5.0 (Sept2022)
Home
Protocol